Crossmark

Where are we now with the treatment of multiple myeloma?

Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.82

Published Online: 2017-06-13

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Morgan, Gareth J.

Rasche, Leo
License Information

Text and Data Mining valid from 2017-06-13
More Information

Article History

First Online: 13 June 2017

Competing interests

: G.J.M. declares he has received consultancy (speaker fees) and honoraria from Celgene, Janssen and Takeda, but has no patents, stocks and/or ownerships. L.R. declares no competing interests.